(Q40379092)

20 September 2017

title

Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination (English)

1 reference

20 September 2017

0 references

0 references

4

1 reference

20 September 2017

Hellebrand E

1

1 reference

20 September 2017

Mautner J

2

1 reference

20 September 2017

Reisbach G

3

1 reference

20 September 2017

Hallek M

5

1 reference

20 September 2017

Mocikat R

6

1 reference

20 September 2017

Hammerschmidt W

7

1 reference

20 September 2017

publication date

1 January 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

13

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

150-162

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302602

20 September 2017

exact match

0 references

cites work

Spinning molecular immunology into successful immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

GM-CSF-secreting melanoma vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

A first-generation packaging cell line for Epstein-Barr virus-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Brefeldin A: insights into the control of membrane traffic and organelle structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

The potential of gene transfer into primary B-CLL cells using recombinant virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Gene therapy progress and prospects: episomally maintained self-replicating systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Gene therapy of B-cell lymphoma with cytokine gene-modified trioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Cytokine-secreting tumor cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Construction of large DNA segments in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

7 January 2021

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

7 January 2021

Murine leukemia induced by retroviral gene marking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

7 January 2021

Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302602

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302602

1 reference

Dimensions Publication ID

20 September 2017

1018433144

0 references

1 reference